Spanish Society of Pharmacology (SEF) partners with Bentham Science Publishers

Bentham Science has entered into a collaboration with Spanish Society of Pharmacology (SEF) for our High Impact journals including Current Neuropharmacology (JCR IF: 7.36), Current Medicinal Chemistry (JCR IF: 4.53), Current Topics in Medicinal Chemistry (JCR IF: 3.295), and Current Pharmaceutical Design (JCR IF: 3.116). This collaboration facilitates members of the society to publish their research in Bentham journals with significant concessions.

The SEF was founded in 1972 to bring together all Spanish pharmacologists, in order to facilitate organizing scientific meetings (an annual meeting at the national level) with the aim of promoting scientific and social exchange among Spanish pharmacologists as well as joint meetings with other Pharmacology Societies within the framework of the International Pharmacology Association and the European Pharmacology Association (IUPHAR and EPHAR). The Society represents researchers in national and international organizations, helps networking at scientific and technical meetings, awards scholarships and prizes to stimulate pharmacological research in Spain. In addition, it manages the operation of different working committees reviewing specific issues in pharmacology and allied research.

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at https://benthamscience.com/index.php.

Learn more in our press release: https://bit.ly/2W75YGo

Press Release: Significant increase in impact factor ratings for Bentham Science journals

Clarivate has recently published the latest edition of Journal Citation Reports® providing information for the category ranking and Impact Factor ratings of the indexed journals in 2020. Bentham Science journals have performed well and received outstanding Impact Factor rankings this year. 35 out of our 40 ranked journals have secured a higher Impact Factor, while 5 journals have, more or less, maintained their ratings.

Current Neuropharmacology has proved to be the most impactful title from our catalog again last year, in terms of publishing quality research that has been readily cited by the researchers worldwide. Its Impact Factor has increased to 7.363 from 4.668 In the previous period.

Other highlights include Current Gene Therapy (Impact Factor 2020: 4.391) and Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2020: 4.169) which have received an appreciable increase in Impact Factors. Here is the list of all of Bentham’s Impact Factor journals.

Bentham Science congratulates all of its contributors and looks forward to raising the bar on publishing impactful research for the benefit of the global scientific community. Read the full Press Release to find out more: https://www.eurekalert.org/pub_releases/2021-07/bsp-sii070621.php

New Issue | Current Molecular Medicine; Volume 20 Issue 1

cm

Current Molecular Medicine

Volume 20, Issue 1

AIMS & SCOPE

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews/ mini-reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Articles from the Journal 

For more details on the articles, please visit HERE 

New Issue | Current Drug Targets; Volume 21 Issue 5

cdt

Current Drug Targets

Volume 21, Issue 5

AIMS & SCOPE

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

 

 

Articles from the Journal 

For more details on the articles, please visit HERE 

Aims & Scope | Letters in Drug Design & Discovery

lddd-flyer

 

AIMS & SCOPE

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

CURRENT NEUROPHARMACOLOGY RESEARCH!

cn-flyer

For more details: https://benthamscience.com/journals/current-neuropharmacology/#top 

Press Release: Bentham Science Journals – Impact Factors 2015

News release date: June 18, 2016

Dubai, UAE, June 18, 2016: According to the recently released Journal Citation Reports® 2015, 39 Bentham Science Journals have received Impact Factors. Current Neuropharmacology has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

  1. Current Neuropharmacology
    Impact Factor: 3.753
  2. Current Cancer Drug Targets
    Impact Factor: 3.707
  3. Current Drug Targets
    Impact Factor: 3.029
  4. Current Gene Therapy
    Impact Factor: 2.738
  5. Anti-Cancer Agents in Medicinal Chemistry
    Impact Factor: 2.722
  6. Current Stem Cell Research and Therapy
    Impact Factor: 2.645
  7. Current Genomics
    Impact Factor: 2.43
  8. Endocrine, Metabolic & Immune Disorders – Drug Targets
    Impact Factor: 1.987
  9. Medicinal-chemistry
    Impact Factor: 1.458
  10. Mini Reviews in Organic Chemistry
    Impact Factor: 1.394

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data. Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Press Release: Bentham Science Journals – Impact Factors 2014

News release date: June 23, 2015
Dubai, UAE, June 23, 2015: According to the recently released Journal Citation Reports® 2014, 39 Bentham Science Journals have received Impact Factors. Recent Patents On Anti-Cancer Research has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.
Following are the top 10 high impact factor journals published by Bentham Science:
Recent Patents On Anti-Cancer Research 4.295
Current Alzheimer Research 3.889
Current Medicinal Chemistry 3.853
Current Molecular Medicine 3.621
Current Pharmaceutical Design 3.452
Current Cancer Drug Targets 3.522
Current Topics in Medicinal Chemistry 3.402
Current Drug Targets 3.021
Current Drug Metabolism 2.976
Mini Reviews Medicinal Chemistry 2.903
Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.
Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Press Release: Bentham Science Journals – Impact Factors 2014

News release date: June 23, 2015

Dubai, UAE, June 23, 2015: According to the recently released Journal Citation Reports® 2014, 39 Bentham Science Journals have received Impact Factors. Recent Patents On Anti-Cancer Research has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Articles from Bentham Science Impact Factor Journals Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Articles from the journal Anti-Cancer Agents in Medicinal Chemistry, 15 Issue 3

Article: Anti-Cancer Agent-Induced Nephrotoxicity

Author(s): Hirotaka Fukasawa, Ryuichi Furuya, Hideo Yasuda, Tatsuo Yamamoto, Akira Hishida and Masatoshi Kitagawa.

Affiliation: Renal Division, Department of Internal Medicine, Iwata City Hospital, 512-3 Ohkubo, Iwata, Shizuoka 438-8550 Japan.

Article: Recent Developments on Thiourea Based Anticancer Chemotherapeutics

Author(s): Vikas Kumar and Swapandeep Singh Chimni

Affiliation: Department of Chemistry,U.G.C. Center of Advance Studies in Chemistry, Guru Nanak Dev University, Amritsar-143005, India

Article: EGFRIndb: Epidermal Growth Factor Receptor Inhibitor

Author(s): Inderjit S. Yadav, Harinder Singh, Mohd. Imran Khan, Ashok Chaudhury, G.P.S. Raghava and Subhash M. Agarwal

Affiliation: Bioinformatics Division, Institute of Cytology and Preventive Oncology, I-7, Sector-39, Noida- 201301, India.

Article: Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines

Author(s): Zongyuan Yang, Xiaoshui Zhou, Yi Liu, Cheng Gong, Xiao Wei, Taoran Zhang, Ding Ma and Qinglei Gao.

Affiliation: Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Anv. Wuhan, Hubei 430030, China.

 

Article: Chalcone-Coumarin Derivatives as Potential Anti-Cancer Drugs: An in vitro and in vivo Investigation

Author(s): Vincent Jamier, Wioleta Marut, Sergio Valente, Christiane Chereau, Sandrine Chouzenoux, Carole Nicco, Herve Lemarechal, Bernard Weill, Gilbert Kirsch, Claus Jacob and Frederic.

Affiliation: Laboratoire d’Immunologie, 24 rue du faubourg St Jacques 75679 Paris cedex 14, France.

Article: Sesamol Ameliorates Cyclophosphamide-Induced Hepatotoxicity by Modulating Oxidative

Stress and Inflammatory Mediators

Author(s): S. Jnaneshwari, M. Hemshekhar, R.M. Thushara, M. Shanmuga Sundaram, M. Sebastin Santhosh, K. Sunitha, R.L. Shankar, K. Kemparaju and K.S. Girish.

Affiliation: Department of studies and Research in Biochemistry, University of Mysore, Mysore-06 and Tumkur University, Tumkur, Karnataka, India.

Article: Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and

Experimental Evaluation as Anticancer Agents

Author(s): Gabriela R. Luna-Palencia, Federico Martinez-Ramos, Ismael Vasquez-Moctezuma, Manuel Jonathan Fragoso-Vazquez, Jessica Elena Mendieta-Wejebe, Itzia I. Padilla-Martínez, Yudibeth Sixto-Lopez, David Mendez-Luna, Jose Trujillo-Ferrara, Marco A. Meraz-Rios, Yadira Fonseca-Sabater and Jose Correa-Basurto.

Affiliation: Molecular Modeling and Drug Design Laboratory, Biophysics and Biocatalysis Lab, Biochemistry Lab, Seccion de Estudios de Posgrado e Investigacion y Departamento de Bioquimica, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Diaz Miron, Distrito Federal 11340, Mexico.

Article: Synthesis and Biological Evaluation of 3-Substituted-4-(4-methylthio phenyl)-1H- Pyrrole Derivatives as Potential Anticancer Agents.

Author(s): Lan Lan, Weixi Qin, Xiaoping Zhan, Zenglu Liu and Zhenmin Mao

Affiliation: School of Pharmacy, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China.

 

Article: Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold.

Author(s): Mohd Rashid, Asif Husain, Mohammad Shaharyar and Mohd

Affiliation: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi 110062, India.

Article: Modeling Study of Phenylsulfonylfuroxan Derivatives as P-gp Inhibitors: A Combined

Approach of CoMFA, CoMSIA and HQSAR

Author(s): Changdev G. Gadhe, Anand Balupuri, Pavithra K. Balasubramanian and Seung Joo

Affiliation: College of Medicine, Chosun University, 375 Seosuk-dong, Dong-gu Gwangju 501-759, Republic of Korea.

Article: Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S),

Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models

Author(s): Yoshiko Kaku, Ayako Tsuchiya, Takeshi Kanno and Tomoyuki

Affiliation: Department of Physiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan.

Article: Toxic effects of Aflatoxin B1 on embryonic development of zebrafish (Danio rerio): Potential activity of Piceatannol encapsulated Chitosan/poly (lactic acid) nanoparticles.

Author(s): Claudio Festuccia, Giovanni Luca Gravina, Andrea Mancini, Paola Muzi, Ernesto Di Cesare, Ralph Kirk, Matthew Smith, Shaun Hughes, Robert Gibson, Lu-Yun Lian, Enrico Ricevuto and Andrew J. Carnell.

Affiliation: Dipartimento di Medicina Sperimentale, Radiobiology Laboratory, Universita dell’Aquila, Via Vetoio, Coppito 2, 67100 L’Aquila, Italia.

Article: Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum-

Containing Anticancer Agents

Author(s): Masaki Akiyama, Hiroto Izumi, Ke-Yong Wang, Takahiro Yamaguchi, Akihiro Kuma, Noriaki Kitamura, Yoshikazu Harada, Ryoichi Oya, Koji Yamaguchi, Yoshiko Iwai and Kimitoshi.

Affiliation: President Laboratory, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.

Article: ent-Kaurane Diterpenoids from Croton tonkinensis Induce Apoptosis in Colorectal Cancer Cells through the Phosphorylation of JNK Mediated by Reactive Oxygen Species and Dual-Specificity JNK Kinase MKK4.

Author(s): Phuong Thien Thuong, Nguyen Minh Khoi, Saho Ohta, Shinichiro Shiota, Hironori Kanta, Kenji Takeuchi and Fumiaki Ito.

Affiliation: Institute of Health Sciences, Sunstar Inc., Takatsuki, Osaka 569-1195, Japan.

For details, please visit: http://benthamscience.com/journal/index.php?journalID=acamc

%d bloggers like this: